Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
WhiteOak Capital Pharma and Healthcare Fund Direct Growth
NAV: 18 Sep '26
₹17.79
Min. for SIP
₹100
Fund size (AUM)
₹902.24 Cr
Expense ratio
1.09%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,467 | +3.11% | |
| 6 months | ₹30,000 | ₹33,337 | +11.12% | |
| 1 year | ₹60,000 | ₹70,816 | +18.03% |
Holdings (67)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Divi's Laboratories Ltd | Healthcare | Equity | 8.45% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 7.40% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 6.78% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 4.73% |
| Laurus Labs Ltd | Healthcare | Equity | 3.78% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 3.32% |
| Cipla Ltd | Healthcare | Equity | 3.25% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 3.05% |
| Neuland Laboratories Ltd | Healthcare | Equity | 2.88% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.66% |
| Others CBLO | Unspecified | CBLO | 2.58% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 2.58% |
| CORONA Remedies Ltd. | Healthcare | Equity | 2.35% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 2.35% |
| Thyrocare Technologies Ltd | Healthcare | Equity | 2.31% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 2.21% |
| Shaily Engineering Plastics Ltd | Materials | Equity | 2.01% |
| Cipla Ltd Futures | Healthcare | Futures | 2.00% |
| Global Health Ltd | Healthcare | Equity | 1.92% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 1.92% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 1.76% |
| Ajanta Pharma Ltd | Healthcare | Equity | 1.72% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 1.68% |
| Fortis Healthcare Ltd | Healthcare | Equity | 1.65% |
| Aurobindo Pharma Ltd Futures | Healthcare | Futures | 1.62% |
| Vijaya Diagnostic Centre Ltd | Healthcare | Equity | 1.59% |
| Navin Fluorine International Ltd | Materials | Equity | 1.53% |
| Ami Organics Ltd | Healthcare | Equity | 1.44% |
| Laurus Labs Limited | Healthcare | Futures | 1.36% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 1.27% |
| Procter & Gamble Health Ltd | Healthcare | Equity | 1.25% |
| Manipal Health Enterprises Ltd | Healthcare | Equity | 1.15% |
| Pfizer Ltd | Healthcare | Equity | 1.14% |
| Aarti Pharmalabs Ltd. | Healthcare | Equity | 1.10% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 1.01% |
| Kovai Medical Center & Hospital Ltd | Healthcare | Equity | 0.99% |
| Molbio Diagnostics Ltd. | Healthcare | Equity | 0.98% |
| Aether Industries Ltd | Materials | Equity | 0.97% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | Equity | 0.87% |
| Senores Pharmaceuticals Ltd. | Healthcare | Equity | 0.85% |
| Gland Pharma Ltd | Healthcare | Equity | 0.85% |
| Poly Medicure Ltd | Healthcare | Equity | 0.76% |
| Vimta Labs Ltd | Healthcare | Equity | 0.73% |
| GOVERNMENT OF INDIA 37816 091 DAYS TBILL 05NV26 FV RS 100 | Financial | Treasury Bills | 0.61% |
| Nephrocare Health Services Ltd. | Healthcare | Equity | 0.61% |
| Innova Captab Ltd. | Healthcare | Equity | 0.61% |
| Supriya Lifescience Ltd | Healthcare | Equity | 0.60% |
| GOVERNMENT OF INDIA 37424 182 DAYS TBILL 05NV26 FV RS 100 | Financial | Treasury Bills | 0.48% |
| Biocon Ltd | Healthcare | Equity | 0.48% |
| Sudeep Pharma Ltd. | Healthcare | Equity | 0.47% |
| Orchid Pharma Ltd | Healthcare | Equity | 0.41% |
| MAX Healthcare Institute Ltd $$ | Healthcare | Futures | 0.40% |
| Tatva Chintan Pharma Chem Ltd | Materials | Equity | 0.39% |
| GOVERNMENT OF INDIA 37705 091 DAYS TBILL 29OT26 FV RS 100 | Financial | Treasury Bills | 0.37% |
| Zota Health Care Ltd | Healthcare | Equity | 0.34% |
| GOVERNMENT OF INDIA 37477 091 DAYS TBILL 03SP26 FV RS 100 | Financial | Treasury Bills | 0.33% |
| GOVERNMENT OF INDIA 37846 091 DAYS TBILL 19NV26 FV RS 100 | Financial | Treasury Bills | 0.33% |
| Laxmi Dental Ltd. | Healthcare | Equity | 0.24% |
| Apollo Hospitals Enterprise Ltd Futures | Healthcare | Futures | 0.23% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 0.21% |
| GOVERNMENT OF INDIA 37693 091 DAYS TBILL 22OT26 FV RS 100 | Financial | Treasury Bills | 0.18% |
| GOVERNMENT OF INDIA 37490 091 DAYS TBILL 10SP26 FV RS 100 | Financial | Treasury Bills | 0.13% |
| GOVERNMENT OF INDIA 37436 182 DAYS TBILL 12NV26 FV RS 100 | Financial | Treasury Bills | 0.08% |
| Sun Pharmaceutical Inds. Ltd Futures | Healthcare | Futures | 0.07% |
| Bharat Parenterals Ltd | Healthcare | Equity | 0.04% |
| GOVERNMENT OF INDIA 36692 364 DAYS TBILL 06NV26 FV RS 100 | Financial | Treasury Bills | 0.01% |
| Net Payables | Unspecified | Net Payables | -4.42% |
See All
Minimum investments
Min. for 1st investment
₹500
Min. for 2nd investment
₹500
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +12.3% | +23.2% | +22.7% | +77.6% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 4 | 5 | 4 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
RMRamesh MantriJan 2024 - PresentView details
RM
Ramesh Mantri
Jan 2024 - Present
View details
DPDheeresh PathakJan 2024 - PresentView details
DP
Dheeresh Pathak
Jan 2024 - Present
View details
AAAshish AgrawalJan 2025 - PresentView details
AA
Ashish Agrawal
Jan 2025 - Present
View details
PBPiyush BaranwalJan 2024 - PresentView details
PB
Piyush Baranwal
Jan 2024 - Present
View details
TATrupti AgrawalMay 2025 - PresentView details
TA
Trupti Agrawal
May 2025 - Present
View details
About WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by WhiteOak Capital Mutual Fund. This scheme was made available to investors on 03 Jul 2018. Ramesh Mantri is the Current Fund Manager of WhiteOak Capital Pharma and Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹46,592 Cr and the Latest NAV as of 18 Sep 2026 is ₹17.79.
The WhiteOak Capital Pharma and Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹500.
;
Investment Objective
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)--
Total AUM₹46,591.86 Cr
Date of Incorporation03 Jul 2018
Launch Date03 Jul 2018
AddressUnit No. B4, 6th Floor,Cnergy, Appasaheb Marathe Marg,Prabhadevi Mumbai 400025
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,